Screener
Kura Oncology KURA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 45,466 | 61,697 |
| Current operating lease liabilities | 1,283 | 1,277 |
| Current portion of contract liabilities | 47,704 | 48,983 |
| Total current liabilities | 101,496 | 116,974 |
| Long-term debt, net | 9,749 | 9,711 |
| Long-term operating lease liabilities | 13,241 | 9,469 |
| Other long-term liabilities | 3,437 | 3,165 |
| Long-term contract liabilities | 416,745 | 424,909 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's total current liabilities?
- Kura Oncology (KURA) reported total current liabilities of $101.5M in Q1 2026.
- How has Kura Oncology's total current liabilities changed year-over-year?
- Kura Oncology's total current liabilities increased by 13.1% year-over-year, from $89.77M to $101.5M.
- What is the long-term trend for Kura Oncology's total current liabilities?
- Over 5 years (2020 to 2025), Kura Oncology's total current liabilities has grown at a 35.1% compound annual growth rate (CAGR), from $26.02M to $116.97M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Kura Oncology's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude